CVRx, Inc. (CVRX)
NASDAQ: CVRX · IEX Real-Time Price · USD
8.29
+0.21 (2.60%)
At close: May 17, 2024, 4:00 PM
8.10
-0.19 (-2.29%)
After-hours: May 17, 2024, 5:36 PM EDT
CVRx, Inc. Market Cap
CVRx, Inc. has a market cap or net worth of $179.24 million as of May 17, 2024. Its market cap has decreased by -26.90% in one year.
Market Cap
179.24M
Enterprise Value
129.49M
1-Year Change
-26.90%
Ranking
Category
Stock Price
$8.29
Market Cap Chart
Since the IPO on June 30, 2021, CVRx, Inc.'s market cap has decreased from $347.31M to $179.24M, a decrease of -48.39%. That is a compound annual growth rate of -20.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 17, 2024 | 179.00M | 2.58% |
| May 16, 2024 | 174.50M | 0.23% |
| May 15, 2024 | 174.10M | 4.44% |
| May 14, 2024 | 166.70M | 0.36% |
| May 13, 2024 | 166.10M | 5.80% |
| May 10, 2024 | 157.00M | 2.61% |
| May 9, 2024 | 153.00M | -6.13% |
| May 8, 2024 | 163.00M | -3.83% |
| May 7, 2024 | 169.50M | 1.62% |
| May 6, 2024 | 166.80M | -13.58% |
| May 3, 2024 | 193.00M | 8.73% |
| May 2, 2024 | 177.50M | -16.19% |
| May 1, 2024 | 211.80M | -34.75% |
| Apr 30, 2024 | 324.60M | 1.50% |
| Apr 29, 2024 | 319.80M | 4.03% |
| Apr 26, 2024 | 307.40M | 2.06% |
| Apr 25, 2024 | 301.20M | -0.07% |
| Apr 24, 2024 | 301.40M | 0.77% |
| Apr 23, 2024 | 299.10M | -2.70% |
| Apr 22, 2024 | 307.40M | -1.41% |
| Apr 19, 2024 | 311.80M | -2.38% |
| Apr 18, 2024 | 319.40M | -2.86% |
| Apr 17, 2024 | 328.80M | -4.08% |
| Apr 16, 2024 | 342.80M | -1.49% |
| Apr 15, 2024 | 348.00M | -3.49% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abeona Therapeutics | 183.28M |
| Greenwich LifeSciences | 182.74M |
| Outlook Therapeutics | 181.51M |
| Orchestra BioMed Holdings | 180.73M |
| Biodesix | 180.06M |
| Telomir Pharmaceuticals | 179.14M |
| Lifecore Biomedical | 177.63M |
| Stereotaxis | 173.14M |